BeOne Medicines
ONC
#718
Rank
HK$257.97 B
Marketcap
HK$2,233
Share price
-4.55%
Change (1 day)
15.02%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2025 (TTM): HK$5.15

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is HK$5.09. In 2024 the company made an earnings per share (EPS) of -HK$48.84.

EPS history for BeOne Medicines from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$5.15-110.54%
2024-HK$48.84
2022-HK$152.6228.21%
2021-HK$119.04-19.96%
2020-HK$148.7320.81%
2019-HK$123.1131.52%
2018-HK$93.61417.57%
2017-HK$18.09-37.16%
2016-HK$28.78158.95%
2015-HK$11.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-HK$1.88-136.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-HK$7.44-246.15%๐Ÿ‡บ๐Ÿ‡ธ USA